Verna EC - Search Results

1

Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium.

Tran BV, Moris D, Markovic D, Zaribafzadeh H, Henao R, Lai Q, Florman SS, Tabrizian P, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Hoteit M, Levine MH, Cillo U, Vitale A, Verna EC, Halazun KJ, Tevar AD, Humar A, Chapman WC, Vachharajani N, Aucejo F, Lerut J, Ciccarelli O, Nguyen MH, Melcher ML, Viveiros A, Schaefer B, Hoppe-Lotichius M, Mittler J, Nydam TL, Markmann JF, Rossi M, Mobley C, Ghobrial M, Langnas AN, Carney CA, Berumen J, Schnickel GT, Sudan DL, Hong JC, Rana A, Jones CM, Fishbein TM, Busuttil RW, Barbas AS, Agopian VG. Tran BV, et al. Among authors: verna ec. Liver Transpl. 2023 Jul 1;29(7):683-697. doi: 10.1097/LVT.0000000000000145. Epub 2023 Apr 10. Liver Transpl. 2023. PMID: 37029083

2

The impact of hepatitis C and biliary complications on patient and graft survival following liver transplantation.

Verna EC, De Martin E, Burra P, Neri D, Gaglio PJ, Emond JC, Brown RS Jr. Verna EC, et al. Am J Transplant. 2009 Jun;9(6):1398-405. doi: 10.1111/j.1600-6143.2009.02649.x. Epub 2009 May 20. Am J Transplant. 2009. PMID: 19459805 Free article.

3

Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C.

Saxena V, Lai JC, O'Leary JG, Verna EC, Brown RS Jr, Stravitz RT, Trotter JF, Krishnan K, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients. Saxena V, et al. Among authors: verna ec. Liver Transpl. 2012 May;18(5):524-31. doi: 10.1002/lt.22461. Liver Transpl. 2012. PMID: 22140019 Free PMC article.

4

Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study.

Lai JC, O'Leary JG, Trotter JF, Verna EC, Brown RS Jr, Stravitz RT, Duman JD, Forman LM, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C). Lai JC, et al. Among authors: verna ec. Liver Transpl. 2012 May;18(5):532-8. doi: 10.1002/lt.23396. Liver Transpl. 2012. PMID: 22271671 Free PMC article.

5

Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donors.

Chang MS, Olsen SK, Pichardo EM, Heese S, Stiles JB, Abdelmessih R, Verna EC, Guarrera JV, Emond JC, Brown RS Jr. Chang MS, et al. Among authors: verna ec. Liver Transpl. 2012 Jul;18(7):834-8. doi: 10.1002/lt.23429. Liver Transpl. 2012. PMID: 22422699 Free article. Clinical Trial.

6

Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus.

Verna EC, Valadao R, Farrand E, Pichardo EM, Lai JC, Terrault NA, Brown RS Jr. Verna EC, et al. Liver Transpl. 2012 Apr;18(4):461-7. doi: 10.1002/lt.23376. Liver Transpl. 2012. PMID: 22467547 Free PMC article.

7

Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation.

Siegel AB, Lim EA, Wang S, Brubaker W, Rodriguez RD, Goyal A, Jacobson JS, Hershman DL, Verna EC, Zaretsky J, Halazun K, Dove L, Brown RS Jr, Neugut AI, Kato T, Remotti H, Coppleson YJ, Emond JC. Siegel AB, et al. Among authors: verna ec. Transplantation. 2012 Sep 15;94(5):539-43. doi: 10.1097/TP.0b013e31825c58ea. Transplantation. 2012. PMID: 22864187 Free PMC article.

8

Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis.

Verna EC, Abdelmessih R, Salomao MA, Lefkowitch J, Moreira RK, Brown RS Jr. Verna EC, et al. Liver Transpl. 2013 Jan;19(1):78-88. doi: 10.1002/lt.23559. Liver Transpl. 2013. PMID: 23081888 Free article.

9

Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.

Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown RS Jr, Kulik LM, Olthoff KM, Saab S, Adeyi O, Argo CK, Everhart JE, Rodrigo del R; A2ALL Study Group. Terrault NA, et al. Hepatology. 2014 Apr;59(4):1311-9. doi: 10.1002/hep.26920. Epub 2014 Mar 1. Hepatology. 2014. PMID: 24677192 Free PMC article.

10

High post-transplant virological response in hepatitis C virus infected patients treated with pretransplant protease inhibitor-based triple therapy.

Verna EC, Shetty K, Lukose T, Terry N, Mentore K, Olsen SK, Fox AN, Dove LM, Brown RS. Verna EC, et al. Liver Int. 2015 Feb;35(2):510-7. doi: 10.1111/liv.12616. Epub 2014 Jul 10. Liver Int. 2015. PMID: 24905624 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

225 results

Search Page